Cohen Veterans Bioscience Joins PRISM 2 Consortium
June 23, 2021The new PRISM 2 project, “Psychiatric Ratings using Intermediate Stratified Markers 2,” aims to identify quantitative biological features common…
Cohen Veterans Bioscience Hosts Voices of Veterans Webinar to Mark ‘Mental Health Action Day’ on May 20, 2021
May 12, 2021To commemorate the first Mental Health Action Day, brain research and advocacy nonprofit Cohen Veterans Bioscience (CVB) announces plans to host a webinar…
Traumatic Brain Injury: A New Roadmap Outlining Opportunities, Barriers, and Recommendations for Advancing Treatment Solutions
April 26, 2021Brain research and advocacy nonprofit Cohen Veterans Bioscience (CVB) today announced the launch of a National TBI Precision Solutions…
Cohen Veterans Bioscience And The European College Of Neuropsychopharmacology Announce The 2021 Best Negative Data Prize In Clinical Neuroscience
March 8, 2021Cohen Veterans Bioscience and the European College of Neuropsychopharmacology (ECNP) are pleased to announce the opening of submissions for…
Parachuting with a Purpose: Local US Marine Corps Veteran BASE Jumps to Raise Awareness of Veteran Suicide
February 1, 2021Pittsburgh Veteran Tristan Wimmer is returning to the skies of his hometown to bring attention to this national crisis….
Cohen Veterans Bioscience Announces Appointment of Dave DeMarco to Board of Directors
January 12, 2021Cohen Veterans Bioscience is pleased to announce the appointment of Dr. Dave DeMarco to its Board of Directors.
New Research Partnership Pushes for Increased Transparency & Publication of Negative Research
November 2, 2020Null Hypothesis is a collaborative initiative dedicated to publishing well-performed replication and negative studies — or studies where the…
New Study Reveals Brain Circuit Biomarkers to Predict Response to Treatment in Patients with Complex Neuropsychiatric Disorders
October 19, 2020Cohen Veterans Bioscience announced findings from a study which generates new evidence in support of a critical brain imaging…
Global Preclinical Data Forum and European College of Neuropsychopharmacology Announce the Winner of the 2020 Best Negative Data Prize
September 14, 2020The Global Preclinical Data Forum (GPDF), a jointly sponsored U.S. and European initiative, funded by Cohen Veterans Bioscience (CVB) and…
New Collaboration Gives Veterans Better Access To Innovative Research Trials
May 7, 2020Cohen Veterans Bioscience announced it is extending its commitment to the brain health of Veterans by supporting the National…
Press Releases
Cohen Veterans Bioscience > Press Releases
WHO WE ARE
Cohen Veterans Bioscience is a non-profit 501(c)(3) biomedical research and technology organization dedicated to advancing brain health by fast-tracking precision diagnostics and tailored therapeutics.
Learn More Donate
